Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,8.383311084895256e-73,87.98141891891892,14601.613495353247,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.3137938594310907e-70,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.1504591487545499e-38,31.625810372771475,2762.769832610455,"['NDUFB9', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'COX11', 'UQCRFS1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'SLC25A5']",1.5876336252812787e-36,0,0,45
3,Nonalcoholic fatty liver disease WP4396,6.600878791717883e-18,8.048786805975304,318.4046043704617,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'MLX', 'UQCRFS1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",6.072808488380452e-16,0,0,36
4,Mitochondrial CIV Assembly WP4922,1.782701953802475e-17,34.21772939346812,1319.6346699589526,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'COX16', 'PET100', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX11', 'COX14', 'COX20']",1.2300643481237077e-15,0,0,19
5,Oxidative phosphorylation WP623,3.4143523780667065e-17,19.8859375,753.9943858805151,"['NDUFB9', 'ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFB10', 'NDUFA5', 'NDUFA2', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'ATP5MG', 'ATP5MF', 'ATP5ME']",1.884722512692822e-15,0,0,22
6,Mitochondrial complex I assembly model OXPHOS system WP4324,1.5130211986503521e-15,19.083745647791826,651.2264834578439,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'TMEM186', 'NDUFS6', 'NDUFS5', 'TMEM126B']",6.95989751379162e-14,0,0,20
7,Mitochondrial complex III assembly WP4921,6.982862085535609e-07,27.858396946564884,394.8826579159622,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",2.7532427651540404e-05,0,0,7
8,Cellular Proteostasis WP4918,0.0001711603215045473,31.699088145896656,274.9233350221268,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.005905031091906882,0,0,4
9,Pyrimidine metabolism WP4022,0.00020067380313500794,4.281967704469672,36.455944408352316,"['NT5C', 'POLE4', 'POLD4', 'POLR3GL', 'POLE3', 'NME2', 'TK1', 'POLR2I', 'POLR2K', 'NME1', 'POLR2L']",0.0061539966294735775,0,0,11
10,Nucleotide Excision Repair WP4753,0.0029422638975627334,5.012195121951219,29.213959998495472,"['POLE4', 'POLD4', 'RFC2', 'POLE3', 'MNAT1', 'GTF2H5']",0.08120648357273144,0,0,6
11,mRNA Processing WP411,0.0055238825347297855,3.0450620703137727,15.830285951791248,"['LSM7', 'SNRPD1', 'CELF1', 'SNRPG', 'SNRPE', 'SNRPB2', 'SNRPF', 'SRSF9', 'LSM2']",0.1339868542202887,0,0,9
12,DNA Mismatch Repair WP531,0.005825515400882117,7.03951367781155,36.22187255573409,"['POLE4', 'POLD4', 'RFC2', 'POLE3']",0.1339868542202887,0,0,4
13,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.018512600608194853,6.779102536310427,27.04389859211896,"['EIF2S2', 'EIF3D', 'EIF1']",0.3621569971611291,0,0,3
14,Base Excision Repair WP4752,0.019663709046760063,4.523230568823274,17.77168480371369,"['POLE4', 'POLD4', 'APEX1', 'POLE3']",0.3621569971611291,0,0,4
15,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.019682445497887453,15.80151515151515,62.06879604296511,"['ELOB', 'ELOC']",0.3621569971611291,0,0,2
16,DNA Repair Pathways Full Network WP4946,0.02770357100329183,2.395245513819168,8.589814987217423,"['POLE4', 'POLD4', 'CENPX', 'RFC2', 'APEX1', 'POLE3', 'MNAT1', 'GTF2H5']",0.47788659980678405,0,0,8
17,Eukaryotic Transcription Initiation WP405,0.03340033894766005,3.7239406400858215,12.658378920355522,"['GTF2A2', 'POLR2I', 'MNAT1', 'POLR2K']",0.5422643264443632,0,0,4
18,Nanomaterial induced apoptosis WP2507,0.038617674571404866,4.744006069802731,15.437210260197766,"['ENDOG', 'BAX', 'CYCS']",0.5699097299852504,0,0,3
19,Proteasome Degradation WP183,0.039383300772616515,2.932521562658549,9.484987011018404,"['PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMB10']",0.5699097299852504,0,0,5
20,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.04542758717273735,7.899242424242424,24.421579972590912,"['COX8A', 'CYP2C8']",0.5699097299852504,0,0,2
21,Dual hijack model of Vif in HIV infection WP3300,0.04542758717273735,7.899242424242424,24.421579972590912,"['ELOB', 'ELOC']",0.5699097299852504,0,0,2
22,Nanoparticle triggered regulated necrosis WP2513,0.04542758717273735,7.899242424242424,24.421579972590912,"['TRADD', 'FTL']",0.5699097299852504,0,0,2
23,Translation Factors WP107,0.04940685197560426,2.7297538445389176,8.210188264570252,"['EEF1B2', 'EIF1AY', 'EIF2S2', 'EIF3D', 'EIF1']",0.5928822237072511,0,0,5
24,Copper homeostasis WP3286,0.058589815382031465,3.0134607034303085,8.549773821680882,"['SCO2', 'COX17', 'COX11', 'ATOX1']",0.6588346083195583,0,0,4
25,Mitochondrial CII Assembly WP4920,0.059677047855032465,inf,inf,['SDHAF1'],0.6588346083195583,0,0,1
26,Sleep regulation WP3591,0.06610986795646852,2.876208897485493,7.8130410022038514,"['CACNA1I', 'CRH', 'BTBD9', 'HCRTR1']",0.7017816752302043,0,0,4
27,Gastric Cancer Network 2 WP2363,0.08851601006239779,3.161153262518968,7.6644431780222275,"['AHCTF1', 'S100A6', 'COL9A3']",0.9048303250822884,0,0,3
28,Selenium Micronutrient Network WP15,0.10809786118136189,1.9379044300647088,4.311291526904737,"['SELENOM', 'PRDX5', 'SELENOS', 'SELENOW', 'TXN', 'SELENOH']",0.9993220073218276,0,0,6
29,Serotonin and anxiety WP3947,0.11645810040811873,3.9481060606060607,8.489311315657996,"['POMC', 'CRH']",0.9993220073218276,0,0,2
30,Cytosolic DNA-sensing pathway WP4655,0.1207694176528106,2.2585757707338256,4.774340512250141,"['POLR3GL', 'TRADD', 'POLR2K', 'POLR2L']",0.9993220073218276,0,0,4
31,ERK Pathway in Huntington's Disease WP3853,0.13692762421996993,3.5090909090909093,6.977135220744497,"['NTRK2', 'HRAS']",0.9993220073218276,0,0,2
32,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.13692762421996993,3.5090909090909093,6.977135220744497,"['RRAS2', 'HRAS']",0.9993220073218276,0,0,2
33,Overview of nanoparticle effects WP3287,0.13692762421996993,3.5090909090909093,6.977135220744497,"['COL4A1', 'BAX']",0.9993220073218276,0,0,2
34,Heme Biosynthesis WP561,0.16857413150621325,7.888804841149773,14.04506780985401,['HMBS'],0.9993220073218276,0,0,1
35,p38 MAPK Signaling Pathway WP400,0.16973430168539638,2.2566659440711034,4.002244432419445,"['TRADD', 'DDIT3', 'HRAS']",0.9993220073218276,0,0,3
36,Splicing factor NOVA regulated synaptic proteins WP4148,0.18489037204029501,2.1538832942474824,3.6357382286521553,"['KCNQ2', 'GRIK2', 'ANK3']",0.9993220073218276,0,0,3
37,Ciliary landscape WP4352,0.20557780187251562,1.388036809815951,2.1957780682399326,"['COPS6', 'IFT22', 'PSMD7', 'NDUFA5', 'SSNA1', 'MYL6B', 'TMED1', 'SNRPB2', 'COX6C', 'LSM4']",0.9993220073218276,0,0,10
38,MED and Pseudoachondroplasia genes WP4789,0.21820471679554881,5.258698940998487,8.005430927785904,['COL9A3'],0.9993220073218276,0,0,1
39,Mevalonate pathway WP3963,0.21820471679554881,5.258698940998487,8.005430927785904,['PMVK'],0.9993220073218276,0,0,1
40,TP53 network WP1742,0.2243765832233214,2.4284382284382287,3.629129639149484,"['SUMO1', 'BAX']",0.9993220073218276,0,0,2
41,Benzo(a)pyrene metabolism WP696,0.26487689408113896,3.9436459909228443,5.239094702474473,['AKR1A1'],0.9993220073218276,0,0,1
42,Valproic acid pathway WP3871,0.26487689408113896,3.9436459909228443,5.239094702474473,['HSD17B10'],0.9993220073218276,0,0,1
43,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.26487689408113896,3.9436459909228443,5.239094702474473,['PMVK'],0.9993220073218276,0,0,1
44,Peroxiredoxin 2 induced ovarian failure WP4873,0.26487689408113896,3.9436459909228443,5.239094702474473,['BAX'],0.9993220073218276,0,0,1
45,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.26961882618002836,2.104242424242424,2.7581274928214308,"['H2AFJ', 'H2AFZ']",0.9993220073218276,0,0,2
46,Type 2 papillary renal cell carcinoma WP4241,0.2922566777627076,1.972537878787879,2.4264638765602298,"['ELOB', 'ELOC']",0.9993220073218276,0,0,2
47,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.2922566777627076,1.972537878787879,2.4264638765602298,"['GRB10', 'HRAS']",0.9993220073218276,0,0,2
48,TNF-alpha signaling pathway WP231,0.29883259803241286,1.4099532507066754,1.703042679453818,"['TRADD', 'BAX', 'TXN', 'BTRC', 'HRAS']",0.9993220073218276,0,0,5
49,Serotonin and anxiety-related events WP3944,0.30876675714398744,3.1546142208774586,3.707205212721333,['CRH'],0.9993220073218276,0,0,1
50,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.30876675714398744,3.1546142208774586,3.707205212721333,['VEGFB'],0.9993220073218276,0,0,1
51,Glycosylation and related congenital defects WP4521,0.31479773804153977,1.8563279857397506,2.1455901973052427,"['DPM2', 'DPM3']",0.9993220073218276,0,0,2
52,Parkinson's disease pathway WP2371,0.31479773804153977,1.8563279857397506,2.1455901973052427,"['CYCS', 'PARK7']",0.9993220073218276,0,0,2
53,TCA cycle in senescence WP5050,0.3500399339633377,2.628593040847201,2.7592552330126843,['ME1'],0.9993220073218276,0,0,1
54,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.3500399339633377,2.628593040847201,2.7592552330126843,['SST'],0.9993220073218276,0,0,1
55,Codeine and Morphine Metabolism WP1604,0.3500399339633377,2.628593040847201,2.7592552330126843,['CYP2C8'],0.9993220073218276,0,0,1
56,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.3500399339633377,2.628593040847201,2.7592552330126843,['CYP2C8'],0.9993220073218276,0,0,1
57,Insulin signaling in adipocytes (diabetic condition) WP3635,0.3500399339633377,2.628593040847201,2.7592552330126843,['RPS6'],0.9993220073218276,0,0,1
58,Insulin signaling in adipocytes (normal condition) WP3634,0.3500399339633377,2.628593040847201,2.7592552330126843,['RPS6'],0.9993220073218276,0,0,1
59,Purine metabolism WP4792,0.3500399339633377,2.628593040847201,2.7592552330126843,['APRT'],0.9993220073218276,0,0,1
60,7q11.23 copy number variation syndrome WP4932,0.3586779687521817,1.2937595129375952,1.3265308502724913,"['RFC2', 'ATP5MC2', 'ATP5PO', 'ATP5F1E', 'ATP5MC1']",0.9993220073218276,0,0,5
61,CAMKK2  Pathway WP4874,0.3811922918188199,1.5774242424242424,1.5213489058018133,"['CHRM3', 'FIS1']",0.9993220073218276,0,0,2
62,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.3888522072776457,2.2528636265398747,2.127955714674741,['DLL3'],0.9993220073218276,0,0,1
63,Biomarkers for pyrimidine metabolism disorders WP4584,0.3888522072776457,2.2528636265398747,2.127955714674741,['NT5C'],0.9993220073218276,0,0,1
64,Homologous recombination WP186,0.3888522072776457,2.2528636265398747,2.127955714674741,['POLD4'],0.9993220073218276,0,0,1
65,Iron metabolism in placenta WP2007,0.3888522072776457,2.2528636265398747,2.127955714674741,['FTH1'],0.9993220073218276,0,0,1
66,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.3888522072776457,2.2528636265398747,2.127955714674741,['BAX'],0.9993220073218276,0,0,1
67,Modulators of TCR signaling and T cell activation WP5072,0.3976360713417182,1.3521786256232387,1.2470035835444067,"['NDUFB10', 'ELOB', 'RNF7']",0.9993220073218276,0,0,3
68,BDNF-TrkB Signaling WP3676,0.4027380521506846,1.5021645021645023,1.3661719320077854,"['NTRK2', 'HRAS']",0.9993220073218276,0,0,2
69,MAPK Cascade WP422,0.4027380521506846,1.5021645021645023,1.3661719320077854,"['RASA3', 'HRAS']",0.9993220073218276,0,0,2
70,MET in type 1 papillary renal cell carcinoma WP4205,0.4139727880773979,1.3144916540212443,1.1593225348310372,"['RPL11', 'HRAS', 'PAK4']",0.9993220073218276,0,0,3
71,Tamoxifen metabolism WP691,0.4253500987460312,1.9710665658093798,1.6849518401762564,['CYP2C8'],0.9993220073218276,0,0,1
72,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.4253500987460312,1.9710665658093798,1.6849518401762564,['IDH3B'],0.9993220073218276,0,0,1
73,Pyrimidine metabolism and related diseases WP4225,0.4253500987460312,1.9710665658093798,1.6849518401762564,['NT5C'],0.9993220073218276,0,0,1
74,RalA downstream regulated genes WP2290,0.4253500987460312,1.9710665658093798,1.6849518401762564,['HRAS'],0.9993220073218276,0,0,1
75,IL-18 signaling pathway WP4754,0.4385101624182848,1.0956671779141105,0.9032376627548953,"['NRN1', 'RASA3', 'NACA', 'TMSB4X', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'RPS11', 'RND2']",0.9993220073218276,0,0,10
76,Bladder cancer WP2828,0.4447053995515889,1.3712779973649538,1.1112058546806263,"['DAPK1', 'HRAS']",0.9993220073218276,0,0,2
77,Genes targeted by miRNAs in adipocytes WP1992,0.45967141870445244,1.751891074130106,1.3616456906243342,['TMSB4X'],0.9993220073218276,0,0,1
78,"GPCRs, Class B Secretin-like WP334",0.45967141870445244,1.751891074130106,1.3616456906243342,['ADGRL2'],0.9993220073218276,0,0,1
79,VEGFA-VEGFR2 Signaling Pathway WP3888,0.4606699274364496,1.047878801769384,0.8121830747201122,"['RPS6', 'FRS2', 'TXN', 'RPL10A', 'RPL7', 'CYP2C8', 'RPL18A', 'TMSB4X', 'GRB10', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'RPS11', 'TMSB10', 'EIF3D', 'HRAS']",0.9993220073218276,0,0,18
80,Kit receptor signaling pathway WP304,0.4620415916112362,1.2130267304774134,0.9365783835639201,"['RPS6', 'GRB10', 'HRAS']",0.9993220073218276,0,0,3
81,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.4715925637520823,1.1468361425808233,0.8620077789475259,"['POMC', 'RPS6', 'FRS2', 'HRAS']",0.9993220073218276,0,0,4
82,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.47768811215064183,1.182587253414264,0.8736922041940388,"['APEX1', 'RPS6', 'HRAS']",0.9993220073218276,0,0,3
83,Cholesterol Biosynthesis Pathway WP197,0.49194578330052147,1.576550680786687,1.1183841874682516,['PMVK'],0.9993220073218276,0,0,1
84,Fatty acid transporters WP5061,0.49194578330052147,1.576550680786687,1.1183841874682516,['FABP6'],0.9993220073218276,0,0,1
85,Galanin receptor pathway WP4970,0.49194578330052147,1.576550680786687,1.1183841874682516,['POMC'],0.9993220073218276,0,0,1
86,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.49194578330052147,1.576550680786687,1.1183841874682516,['RPS6'],0.9993220073218276,0,0,1
87,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.49194578330052147,1.576550680786687,1.1183841874682516,['BAX'],0.9993220073218276,0,0,1
88,Nucleotide metabolism WP404,0.49194578330052147,1.576550680786687,1.1183841874682516,['NME2'],0.9993220073218276,0,0,1
89,Purine metabolism and related disorders WP4224,0.49194578330052147,1.576550680786687,1.1183841874682516,['APRT'],0.9993220073218276,0,0,1
90,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.49194578330052147,1.576550680786687,1.1183841874682516,['ANAPC11'],0.9993220073218276,0,0,1
91,Regulation of Actin Cytoskeleton WP51,0.49336313592118214,1.0750069290465631,0.7595029219098643,"['FGF17', 'CHRM3', 'TMSB4X', 'BRK1', 'RRAS2', 'PAK4']",0.9993220073218276,0,0,6
92,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.49782347249081993,1.1063829787234043,0.7717129012937991,"['RPS6', 'RRAS2', 'BAX', 'HRAS']",0.9993220073218276,0,0,4
93,IL-2 signaling pathway WP49,0.5044216804536201,1.2127039627039626,0.8299050958368941,"['RPS6', 'HRAS']",0.9993220073218276,0,0,2
94,Interleukin-11 Signaling Pathway WP2332,0.5044216804536201,1.2127039627039626,0.8299050958368941,"['RPS6', 'HRAS']",0.9993220073218276,0,0,2
95,Apoptosis Modulation by HSP70 WP384,0.5222951010343668,1.433090358960253,0.9308244659038633,['CYCS'],0.9993220073218276,0,0,1
96,Transcriptional cascade regulating adipogenesis WP4211,0.5222951010343668,1.433090358960253,0.9308244659038633,['DDIT3'],0.9993220073218276,0,0,1
97,Methionine De Novo and Salvage Pathway WP3580,0.5222951010343668,1.433090358960253,0.9308244659038633,['TXN'],0.9993220073218276,0,0,1
98,MTHFR deficiency WP4288,0.5222951010343668,1.433090358960253,0.9308244659038633,['CYCS'],0.9993220073218276,0,0,1
99,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5222951010343668,1.433090358960253,0.9308244659038633,['SCO2'],0.9993220073218276,0,0,1
100,NOTCH1 regulation of endothelial cell calcification WP3413,0.5222951010343668,1.433090358960253,0.9308244659038633,['DLL3'],0.9993220073218276,0,0,1
101,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5233834321970542,1.1676767676767676,0.7560017482574765,"['NTRK2', 'HRAS']",0.9993220073218276,0,0,2
102,DNA Replication WP466,0.5233834321970542,1.1676767676767676,0.7560017482574765,"['POLD4', 'RFC2']",0.9993220073218276,0,0,2
103,Ferroptosis WP4313,0.5233834321970542,1.1676767676767676,0.7560017482574765,"['FTH1', 'FTL']",0.9993220073218276,0,0,2
104,Intraflagellar transport proteins binding to dynein WP4532,0.5508340302226776,1.3135400907715582,0.7832925003654293,['IFT22'],0.9993220073218276,0,0,1
105,Alzheimer's disease WP2059,0.552431810123798,1.0506828528072838,0.6235017596015929,"['ATP5MD', 'CYCS', 'HSD17B10']",0.9993220073218276,0,0,3
106,Neural Crest Cell Migration in Cancer WP4565,0.5598153833128864,1.0869383490073146,0.6305853508855068,"['NTRK2', 'PAK4']",0.9993220073218276,0,0,2
107,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.5598153833128864,1.0869383490073146,0.6305853508855068,"['NDUFA13', 'COPS6']",0.9993220073218276,0,0,2
108,Hippo-Merlin Signaling Dysregulation WP4541,0.5678896979290664,0.99724486060536,0.5642691376916392,"['NTRK2', 'ITGAE', 'HRAS', 'CDH8', 'PAK4']",0.9993220073218276,0,0,5
109,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.5772711581746759,1.0506060606060605,0.5772483327865433,"['PPP1R14B', 'DDIT3']",0.9993220073218276,0,0,2
110,p53 transcriptional gene network WP4963,0.5772711581746759,1.0506060606060605,0.5772483327865433,"['SIVA1', 'BAX']",0.9993220073218276,0,0,2
111,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5776704098952857,1.2123821715349703,0.6652968965470084,['HRAS'],0.9993220073218276,0,0,1
112,Sphingolipid Metabolism (general overview) WP4725,0.5776704098952857,1.2123821715349703,0.6652968965470084,['CERS6'],0.9993220073218276,0,0,1
113,Sphingolipid Metabolism (integrated pathway) WP4726,0.5776704098952857,1.2123821715349703,0.6652968965470084,['CERS6'],0.9993220073218276,0,0,1
114,Type II diabetes mellitus WP1584,0.5776704098952857,1.2123821715349703,0.6652968965470084,['SURF1'],0.9993220073218276,0,0,1
115,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5776704098952857,1.2123821715349703,0.6652968965470084,['CD63'],0.9993220073218276,0,0,1
116,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5776704098952857,1.2123821715349703,0.6652968965470084,['BAX'],0.9993220073218276,0,0,1
117,Circadian rhythm related genes WP3594,0.5801450938974364,0.9758292238059852,0.5313166120413283,"['KDM5A', 'CAVIN3', 'CRH', 'BTRC', 'RPS27A', 'BTBD9', 'HCRTR1']",0.9993220073218276,0,0,7
118,Apoptosis Modulation and Signaling WP1772,0.5846794526463928,0.9847074468085106,0.528484142410139,"['ENDOG', 'TRADD', 'CYCS', 'BAX']",0.9993220073218276,0,0,4
119,Acute viral myocarditis WP4298,0.5941083625670035,0.9847306525037937,0.5127428969748143,"['ENDOG', 'CYCS', 'BAX']",0.9993220073218276,0,0,3
120,Non-small cell lung cancer WP4255,0.5941083625670035,0.9847306525037937,0.5127428969748143,"['CYCS', 'BAX', 'HRAS']",0.9993220073218276,0,0,3
121,Kallmann's Syndrome WP5074,0.6029056645640148,1.125675383617895,0.5695855956746478,['FRS2'],0.9993220073218276,0,0,1
122,Proteoglycan biosynthesis WP4784,0.6029056645640148,1.125675383617895,0.5695855956746478,['EXT2'],0.9993220073218276,0,0,1
123,Leptin signaling pathway WP2034,0.6074279424935477,0.9645412034312967,0.4808447435861256,"['RPS6', 'BAX', 'HRAS']",0.9993220073218276,0,0,3
124,NRF2 pathway WP2884,0.6097173094464986,0.9488181034640847,0.4694371085884998,"['FTH1', 'ME1', 'TXN', 'SLC6A20', 'FTL']",0.9993220073218276,0,0,5
125,Genotoxicity pathway WP4286,0.6106453326484979,0.9847537878787879,0.485718932855748,"['RPS27', 'TRIAP1']",0.9993220073218276,0,0,2
126,Ebstein-Barr virus LMP1 signaling WP262,0.6266351852768096,1.0505295007564297,0.4910077705713008,['TRADD'],0.9993220073218276,0,0,1
127,miRNA targets in ECM and membrane receptors WP2911,0.6266351852768096,1.0505295007564297,0.4910077705713008,['COL4A1'],0.9993220073218276,0,0,1
128,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6266351852768096,1.0505295007564297,0.4910077705713008,['BAX'],0.9993220073218276,0,0,1
129,Apoptosis WP254,0.6456106895439558,0.9086319598459204,0.39757973247191614,"['TRADD', 'CYCS', 'BAX']",0.9993220073218276,0,0,3
130,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6489486880021634,0.9847768532526475,0.42581911512890125,['RPS6'],0.9993220073218276,0,0,1
131,Metapathway biotransformation Phase I and II WP702,0.6491074238220781,0.9048443814622369,0.39103488213738047,"['GSTK1', 'CYP2C8', 'GSTO1', 'AKR1A1', 'HS6ST3']",0.9993220073218276,0,0,5
132,Prolactin Signaling Pathway WP2037,0.669564526943301,0.8748103186646434,0.35091068404140474,"['RPS6', 'PPIB', 'HRAS']",0.9993220073218276,0,0,3
133,Nanoparticle-mediated activation of receptor signaling WP2643,0.6699305508086022,0.9267598113375456,0.371242582804058,['HRAS'],0.9993220073218276,0,0,1
134,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6699305508086022,0.9267598113375456,0.371242582804058,['HRAS'],0.9993220073218276,0,0,1
135,Synaptic Vesicle Pathway WP2267,0.6712762479750686,0.875,0.3487527144456042,"['SLC32A1', 'PARK7']",0.9993220073218276,0,0,2
136,Unfolded protein response WP4925,0.6896601310465628,0.8751891074130106,0.32518208469895843,['DDIT3'],0.9993220073218276,0,0,1
137,Disruption of postsynaptic signaling by CNV WP4875,0.6896601310465628,0.8751891074130106,0.32518208469895843,['DLGAP1'],0.9993220073218276,0,0,1
138,Imatinib and Chronic Myeloid Leukemia WP3640,0.6896601310465628,0.8751891074130106,0.32518208469895843,['SKP2'],0.9993220073218276,0,0,1
139,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.6896601310465628,0.8751891074130106,0.32518208469895843,['FTL'],0.9993220073218276,0,0,1
140,PDGFR-beta pathway WP3972,0.6896601310465628,0.8751891074130106,0.32518208469895843,['HRAS'],0.9993220073218276,0,0,1
141,Photodynamic therapy-induced unfolded protein response WP3613,0.6896601310465628,0.8751891074130106,0.32518208469895843,['DDIT3'],0.9993220073218276,0,0,1
142,Pregnane X receptor pathway WP2876,0.6896601310465628,0.8751891074130106,0.32518208469895843,['PSMC5'],0.9993220073218276,0,0,1
143,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.6946701104304106,0.8552544504003706,0.3115847682029883,"['NTRK2', 'RPS6', 'FRS2', 'EIF2S2', 'HRAS']",0.9993220073218276,0,0,5
144,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.6986065437583151,0.8287878787878787,0.29725934256390185,"['PSMC5', 'PSMD7']",0.9993220073218276,0,0,2
145,PPAR signaling pathway WP3942,0.6986065437583151,0.8287878787878787,0.29725934256390185,"['FABP6', 'ME1']",0.9993220073218276,0,0,2
146,Androgen receptor signaling pathway WP138,0.703234720915801,0.8285280728376327,0.2916953699520304,"['SUMO1', 'BAG1', 'PARK7']",0.9993220073218276,0,0,3
147,GABA receptor Signaling WP4159,0.7082120634993361,0.8290468986384266,0.28603088437274826,['SLC32A1'],0.9993220073218276,0,0,1
148,SARS-CoV-2 mitochondrial interactions WP5038,0.7082120634993361,0.8290468986384266,0.28603088437274826,['NDUFB9'],0.9993220073218276,0,0,1
149,Thermogenesis WP4321,0.7138594293990328,0.8141646172361467,0.2744298272872911,"['RPS6', 'FRS2', 'HRAS']",0.9993220073218276,0,0,3
150,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7240261430733286,0.7871969696969697,0.25420776829700886,"['IFI27L2', 'HRAS']",0.9993220073218276,0,0,2
151,Oncostatin M Signaling Pathway WP2374,0.7240261430733286,0.7871969696969697,0.25420776829700886,"['RPS6', 'HRAS']",0.9993220073218276,0,0,2
152,Sphingolipid pathway WP1422,0.7256565412426496,0.7875189107413011,0.2525403513477231,['CERS6'],0.9993220073218276,0,0,1
153,Canonical and non-canonical Notch signaling WP3845,0.7256565412426496,0.7875189107413011,0.2525403513477231,['DLL3'],0.9993220073218276,0,0,1
154,Cell migration and invasion through p75NTR WP4561,0.7256565412426496,0.7875189107413011,0.2525403513477231,['NTRK2'],0.9993220073218276,0,0,1
155,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.7256565412426496,0.7875189107413011,0.2525403513477231,['PPIB'],0.9993220073218276,0,0,1
156,Fluoropyrimidine Activity WP1601,0.7256565412426496,0.7875189107413011,0.2525403513477231,['TK1'],0.9993220073218276,0,0,1
157,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7256565412426496,0.7875189107413011,0.2525403513477231,['SUPT4H1'],0.9993220073218276,0,0,1
158,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.7256565412426496,0.7875189107413011,0.2525403513477231,['NTRK2'],0.9993220073218276,0,0,1
159,Prader-Willi and Angelman Syndrome WP3998,0.7360426177343439,0.7679231337767923,0.2353432967020531,"['POMC', 'FEZ1']",0.9993220073218276,0,0,2
160,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7420595795109414,0.7499459693105684,0.22372818865550456,['HRAS'],0.9993220073218276,0,0,1
161,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7420595795109414,0.7499459693105684,0.22372818865550456,['BAX'],0.9993220073218276,0,0,1
162,Ras signaling WP4223,0.7433902496277545,0.8133147603027755,0.24117559065447475,"['NTRK2', 'RASA3', 'RRAS2', 'RASAL2', 'HRAS', 'PAK4']",0.9993220073218276,0,0,6
163,22q11.2 copy number variation syndrome WP4657,0.7439686286396411,0.7738998482549317,0.2288858414733547,"['RANBP1', 'MRPL40', 'PAK4']",0.9993220073218276,0,0,3
164,DNA damage response WP707,0.7476103832395546,0.7495670995670995,0.2180290668664286,"['CYCS', 'BAX']",0.9993220073218276,0,0,2
165,MECP2 and Associated Rett Syndrome WP3584,0.7476103832395546,0.7495670995670995,0.2180290668664286,"['SST', 'RPS6']",0.9993220073218276,0,0,2
166,Amyotrophic lateral sclerosis (ALS) WP2447,0.7574832638552581,0.7157887498280842,0.19881307086085187,['BAX'],0.9993220073218276,0,0,1
167,Vitamin D-sensitive calcium signaling in depression WP4698,0.7574832638552581,0.7157887498280842,0.19881307086085187,['KCNQ2'],0.9993220073218276,0,0,1
168,Endothelin Pathways WP2197,0.7574832638552581,0.7157887498280842,0.19881307086085187,['RIIAD1'],0.9993220073218276,0,0,1
169,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7574832638552581,0.7157887498280842,0.19881307086085187,['DDIT3'],0.9993220073218276,0,0,1
170,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7574832638552581,0.7157887498280842,0.19881307086085187,['BAX'],0.9993220073218276,0,0,1
171,miRNA regulation of DNA damage response WP1530,0.7587401082079217,0.7320648343904158,0.20212015322716967,"['CYCS', 'BAX']",0.9993220073218276,0,0,2
172,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7694427874226512,0.7153581267217631,0.18748726629796228,"['BAX', 'HRAS']",0.9993220073218276,0,0,2
173,Integrin-mediated Cell Adhesion WP185,0.7714994368776588,0.7374099013657056,0.1912983877722135,"['ITGAE', 'HRAS', 'PAK4']",0.9993220073218276,0,0,3
174,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7719859838954907,0.6846017233440769,0.1771673164465182,['HRAS'],0.9993220073218276,0,0,1
175,White fat cell differentiation WP4149,0.7719859838954907,0.6846017233440769,0.1771673164465182,['DDIT3'],0.9993220073218276,0,0,1
176,PDGF Pathway WP2526,0.7719859838954907,0.6846017233440769,0.1771673164465182,['HRAS'],0.9993220073218276,0,0,1
177,Endometrial cancer WP4155,0.7797296648047142,0.6993939393939393,0.17401480934025498,"['BAX', 'HRAS']",0.9993220073218276,0,0,2
178,Melanoma WP4685,0.7797296648047142,0.6993939393939393,0.17401480934025498,"['BAX', 'HRAS']",0.9993220073218276,0,0,2
179,Heart Development WP1591,0.7856226531790493,0.6560136157337367,0.15828210375639423,['VEGFB'],0.9993220073218276,0,0,1
180,Myometrial relaxation and contraction pathways WP289,0.7867943820836413,0.7556931272684697,0.1812063950217792,"['RGS19', 'GSTO1', 'CRH', 'IGFBP6', 'RGS6']",0.9993220073218276,0,0,5
181,Small cell lung cancer WP4658,0.7965624497911638,0.7041877109143206,0.16016731700034192,"['COL4A1', 'CYCS', 'BAX']",0.9993220073218276,0,0,3
182,Alpha 6 Beta 4 signaling pathway WP244,0.7984449153092817,0.6297125567322239,0.1417415579142937,['HRAS'],0.9993220073218276,0,0,1
183,Aryl Hydrocarbon Receptor Pathway WP2873,0.7984449153092817,0.6297125567322239,0.1417415579142937,['BAX'],0.9993220073218276,0,0,1
184,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7984449153092817,0.6297125567322239,0.1417415579142937,['CYCS'],0.9993220073218276,0,0,1
185,Rett syndrome causing genes WP4312,0.7984449153092817,0.6297125567322239,0.1417415579142937,['GPS2'],0.9993220073218276,0,0,1
186,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7991018312329488,0.6695035460992907,0.15014748012618662,"['CYCS', 'BAX']",0.9993220073218276,0,0,2
187,Tryptophan metabolism WP465,0.81050133908592,0.6054346561154428,0.12720320505257762,['HSD17B10'],0.9993220073218276,0,0,1
188,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.81050133908592,0.6054346561154428,0.12720320505257762,['HRAS'],0.9993220073218276,0,0,1
189,Notch Signaling WP268,0.81050133908592,0.6054346561154428,0.12720320505257762,['DLL3'],0.9993220073218276,0,0,1
190,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8218376006592647,0.5829551185073122,0.11438306344068445,['CYCS'],0.9993220073218276,0,0,1
191,Integrated Cancer Pathway WP1971,0.8218376006592647,0.5829551185073122,0.11438306344068445,['BAX'],0.9993220073218276,0,0,1
192,Monoamine GPCRs WP58,0.8218376006592647,0.5829551185073122,0.11438306344068445,['CHRM3'],0.9993220073218276,0,0,1
193,Oxidative Damage WP3941,0.8218376006592647,0.5829551185073122,0.11438306344068445,['CYCS'],0.9993220073218276,0,0,1
194,Regulation of Microtubule Cytoskeleton WP2038,0.8218376006592647,0.5829551185073122,0.11438306344068445,['PARD6A'],0.9993220073218276,0,0,1
195,Wnt Signaling Pathway WP363,0.832496655932632,0.5620812621569051,0.10304415107893293,['RYK'],0.9993220073218276,0,0,1
196,Neural Crest Cell Migration during Development WP4564,0.832496655932632,0.5620812621569051,0.10304415107893293,['PAK4'],0.9993220073218276,0,0,1
197,Oxidation by Cytochrome P450 WP43,0.832496655932632,0.5620812621569051,0.10304415107893293,['CYP2C8'],0.9993220073218276,0,0,1
198,Head and Neck Squamous Cell Carcinoma WP4674,0.8410636035450292,0.6048368298368298,0.10468999320893015,"['RPS6', 'HRAS']",0.9993220073218276,0,0,2
199,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8425189023182837,0.5426469821065262,0.0929875424374054,['BAX'],0.9993220073218276,0,0,1
200,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8425189023182837,0.5426469821065262,0.0929875424374054,['HRAS'],0.9993220073218276,0,0,1
201,Exercise-induced Circadian Regulation WP410,0.8425189023182837,0.5426469821065262,0.0929875424374054,['SUMO1'],0.9993220073218276,0,0,1
202,IL-5 signaling pathway WP127,0.8425189023182837,0.5426469821065262,0.0929875424374054,['RPS6'],0.9993220073218276,0,0,1
203,Pre-implantation embryo WP3527,0.8425189023182837,0.5426469821065262,0.0929875424374054,['DDIT3'],0.9993220073218276,0,0,1
204,"GPCRs, Other WP117",0.8484391693488803,0.5933676386506576,0.09752405904180926,"['CHRM3', 'ADGRL2']",0.9993220073218276,0,0,2
205,Breast cancer pathway WP4262,0.8498534556355486,0.6613981762917933,0.10760376185503719,"['FGF17', 'BAX', 'HRAS', 'DLL3']",0.9993220073218276,0,0,4
206,Aryl Hydrocarbon Receptor Netpath WP2586,0.8519423307377899,0.5245083207261725,0.08404534678272567,['HRAS'],0.9993220073218276,0,0,1
207,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8519423307377899,0.5245083207261725,0.08404534678272567,['PAK4'],0.9993220073218276,0,0,1
208,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.8608026688908129,0.5075398955639061,0.07607514941499448,['PMVK'],0.9993220073218276,0,0,1
209,Corticotropin-releasing hormone signaling pathway WP2355,0.8622634934645934,0.5716804407713498,0.08471982742349944,"['POMC', 'CRH']",0.9993220073218276,0,0,2
210,Retinoblastoma gene in cancer WP2446,0.8622634934645934,0.5716804407713498,0.08471982742349944,"['H2AFZ', 'SKP2']",0.9993220073218276,0,0,2
211,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8691335159979752,0.4916319969742814,0.06895557738783945,['RPS6'],0.9993220073218276,0,0,1
212,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8691335159979752,0.4916319969742814,0.06895557738783945,['BAX'],0.9993220073218276,0,0,1
213,Prostaglandin Synthesis and Regulation WP98,0.8691335159979752,0.4916319969742814,0.06895557738783945,['S100A6'],0.9993220073218276,0,0,1
214,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8769664690903471,0.47668821345069456,0.06258273714053961,['RPS6'],0.9993220073218276,0,0,1
215,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8769664690903471,0.47668821345069456,0.06258273714053961,['TRADD'],0.9993220073218276,0,0,1
216,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8843312424469827,0.46262347601673043,0.0568673328831732,['TRADD'],0.9993220073218276,0,0,1
217,TGF-beta Signaling Pathway WP366,0.8849715179485241,0.5816894284269094,0.07108234205426062,"['PARD6A', 'SUMO1', 'BTRC']",0.9993220073218276,0,0,3
218,ErbB signaling pathway WP673,0.8865050528865733,0.5327170005136107,0.06417559329477959,"['HRAS', 'PAK4']",0.9993220073218276,0,0,2
219,TGF-beta Receptor Signaling WP560,0.8912557795981199,0.44936243786470714,0.05173232151337166,['HRAS'],0.9993220073218276,0,0,1
220,Interferon type I signaling pathways WP585,0.8912557795981199,0.44936243786470714,0.05173232151337166,['RPS6'],0.9993220073218276,0,0,1
221,Pathways in clear cell renal cell carcinoma WP4018,0.8970858196897218,0.5151515151515151,0.055947385011501496,"['ME1', 'GRB10']",0.9993220073218276,0,0,2
222,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8977663585303004,0.43683812405446293,0.047110992857824004,['RNF7'],0.9993220073218276,0,0,1
223,IL-3 signaling pathway WP286,0.8977663585303004,0.43683812405446293,0.047110992857824004,['HRAS'],0.9993220073218276,0,0,1
224,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9038876908529977,0.4249908001799076,0.04294538924491584,['HRAS'],0.9993220073218276,0,0,1
225,Netrin-UNC5B signaling pathway WP4747,0.9038876908529977,0.4249908001799076,0.04294538924491584,['DAPK1'],0.9993220073218276,0,0,1
226,Notch Signaling Pathway Netpath WP61,0.9096430154147616,0.41376701966717094,0.0391849975893702,['DLL3'],0.9993220073218276,0,0,1
227,EGF/EGFR signaling pathway WP437,0.9117493717552273,0.5756671593095564,0.05318596849063735,"['NDUFA13', 'GRB10', 'NEDD8', 'HRAS']",0.9993220073218276,0,0,4
228,Proximal tubule transport WP4917,0.9150541852872202,0.403118817642267,0.0357856622957713,['SLC6A20'],0.9993220073218276,0,0,1
229,Complement system WP2806,0.9155467060052359,0.4832634032634033,0.04264021442631414,"['RPS19', 'TXN']",0.9993220073218276,0,0,2
230,Pancreatic adenocarcinoma pathway WP4263,0.9155467060052359,0.4832634032634033,0.04264021442631414,"['BAX', 'PAK4']",0.9993220073218276,0,0,2
231,Pathways Regulating Hippo Signaling WP4540,0.9155467060052359,0.4832634032634033,0.04264021442631414,"['NTRK2', 'CDH8']",0.9993220073218276,0,0,2
232,Integrated breast cancer pathway WP1984,0.9184136445780344,0.5289935380470921,0.04502126285517963,"['TRADD', 'BAX', 'FAU']",0.9993220073218276,0,0,3
233,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9201417507916845,0.3930030257186082,0.03270867656018744,['TMSB4X'],0.9993220073218276,0,0,1
234,Peptide GPCRs WP24,0.9294222159065225,0.37421655500324186,0.027389717640559395,['HCRTR1'],0.9993220073218276,0,0,1
235,ESC Pluripotency Pathways WP3931,0.9308641682182887,0.45507246376811594,0.03260226101525223,"['FGF17', 'HRAS']",0.9993220073218276,0,0,2
236,Hepatitis B infection WP4666,0.9315724386469223,0.5060453277203975,0.035869164034316475,"['CYCS', 'BAX', 'HRAS']",0.9993220073218276,0,0,3
237,MAPK Signaling Pathway WP382,0.9365129352821236,0.5871379573170732,0.03851152050154867,"['FGF17', 'CACNA1I', 'NTRK2', 'DDIT3', 'RRAS2', 'HRAS']",0.9993220073218276,0,0,6
238,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9373928947913363,0.4952959028831563,0.03202225368589974,"['COL4A1', 'HRAS', 'DLL3']",0.9993220073218276,0,0,3
239,Pathways affected in adenoid cystic carcinoma WP3651,0.9376255891644993,0.3571379452619997,0.023001315200356018,['HRAS'],0.9993220073218276,0,0,1
240,DNA damage response (only ATM dependent) WP710,0.9405869918258531,0.4359848484848485,0.026704568653452634,"['BAX', 'HRAS']",0.9993220073218276,0,0,2
241,Mesodermal commitment pathway WP2857,0.942753131226926,0.4849897532969354,0.028590544363085585,"['EXT2', 'RPL38', 'AHDC1']",0.9993220073218276,0,0,3
242,16p11.2 proximal deletion syndrome WP4949,0.9448767105479137,0.34154443201999607,0.01936585107937613,['TMEM219'],0.9993220073218276,0,0,1
243,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9448767105479137,0.34154443201999607,0.01936585107937613,['CTSV'],0.9993220073218276,0,0,1
244,Endochondral Ossification WP474,0.9448767105479137,0.34154443201999607,0.01936585107937613,['CTSV'],0.9993220073218276,0,0,1
245,G1 to S cell cycle control WP45,0.9448767105479137,0.34154443201999607,0.01936585107937613,['MNAT1'],0.9993220073218276,0,0,1
246,Cell cycle WP179,0.94633184924699,0.4241195741195741,0.023395275222404026,"['SKP2', 'ANAPC11']",0.9993220073218276,0,0,2
247,Gastrin signaling pathway WP4659,0.94633184924699,0.4241195741195741,0.023395275222404026,"['RPS6', 'HRAS']",0.9993220073218276,0,0,2
248,AGE/RAGE pathway WP2324,0.9512859697174221,0.327250378214826,0.016343066302246634,['CYCS'],0.9993220073218276,0,0,1
249,Nuclear Receptors Meta-Pathway WP2882,0.9522779723607605,0.5791348600508905,0.02831870956951816,"['PSMC5', 'FTH1', 'ME1', 'BAX', 'TXN', 'SLC6A20', 'FTL']",0.9993220073218276,0,0,7
250,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9542058618107835,0.3205409243879095,0.01502562596690872,['RYK'],0.9993220073218276,0,0,1
251,Calcium Regulation in the Cardiac Cell WP536,0.954347109996351,0.4609925912701955,0.021541181939640625,"['CHRM3', 'RGS19', 'RGS6']",0.9993220073218276,0,0,3
252,T-cell receptor (TCR) signaling pathway WP69,0.961958039417736,0.301960898405679,0.011711386561929785,['HRAS'],0.9993220073218276,0,0,1
253,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.961958039417736,0.301960898405679,0.011711386561929785,['RYK'],0.9993220073218276,0,0,1
254,Endoderm differentiation WP2853,0.9625463820770329,0.3872053872053872,0.014780800852478978,"['AHDC1', 'NME1']",0.9993220073218276,0,0,2
255,Spinal Cord Injury WP2431,0.9644384377655132,0.38244641537324464,0.013848108117968981,"['COL4A1', 'APEX1']",0.9993220073218276,0,0,2
256,Adipogenesis WP236,0.9695793012958897,0.36884135472370766,0.011394620238359118,"['CELF1', 'DDIT3']",0.9993220073218276,0,0,2
257,Focal Adhesion WP306,0.971051770183257,0.4601734310745575,0.013517822670841563,"['COL4A1', 'VEGFB', 'HRAS', 'PAK4']",0.9993220073218276,0,0,4
258,Glioblastoma signaling pathways WP2261,0.9737515105180529,0.2705670614012207,0.007196848591536023,['HRAS'],0.9993220073218276,0,0,1
259,G Protein Signaling Pathways WP35,0.9753261864326298,0.26595553732146976,0.00664445063149811,['HRAS'],0.9993220073218276,0,0,1
260,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9777980331735298,0.3443223443223443,0.007730773590371055,"['NTRK2', 'SST']",0.9993220073218276,0,0,2
261,PI3K-Akt signaling pathway WP4172,0.9806046781115343,0.5102304344724263,0.009993311609860231,"['FGF17', 'NTRK2', 'COL4A1', 'RPS6', 'VEGFB', 'COL9A3', 'HRAS']",0.9993220073218276,0,0,7
262,Senescence and Autophagy in Cancer WP615,0.9818923837778301,0.24505956883509833,0.004478112071215558,['HRAS'],0.9993220073218276,0,0,1
263,Neural Crest Differentiation WP2064,0.9818923837778301,0.24505956883509833,0.004478112071215558,['DLL3'],0.9993220073218276,0,0,1
264,B Cell Receptor Signaling Pathway WP23,0.9840009096855332,0.23758767707330491,0.0038319227410678887,['HRAS'],0.9993220073218276,0,0,1
265,Wnt signaling WP428,0.9840009096855332,0.23758767707330491,0.0038319227410678887,['RYK'],0.9993220073218276,0,0,1
266,Male infertility WP4673,0.9840009096855332,0.23758767707330491,0.0038319227410678887,['PEX10'],0.9993220073218276,0,0,1
267,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9854515632337476,0.4702782203701434,0.006892069828058883,"['FGF17', 'COL4A1', 'RPS6', 'VEGFB', 'ITGAE', 'HRAS']",0.9993220073218276,0,0,6
268,Insulin Signaling WP481,0.9854837240984351,0.3162534435261708,0.004624469076989722,"['GRB10', 'HRAS']",0.9993220073218276,0,0,2
269,Fragile X Syndrome  WP4549,0.9867129191643075,0.22719200157863578,0.0030389529059233365,['NTRK2'],0.9993220073218276,0,0,1
270,"GPCRs, Class A Rhodopsin-like WP455",0.9900142217361421,0.3498176794328811,0.0035107599344787643,"['CHRM3', 'OR6A2', 'HCRTR1']",0.9993220073218276,0,0,3
271,Osteoblast differentiation WP4787,0.9919048080421556,0.20343045759082068,0.0016535104129446283,['DLL3'],0.9993220073218276,0,0,1
272,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.992848346663517,0.198242019188418,0.0014228521568819552,['HRAS'],0.9993220073218276,0,0,1
273,Ectoderm Differentiation WP2858,0.9968054509105541,0.17001578635795567,0.000543993145272492,['CDH8'],0.9993220073218276,0,0,1
274,Chemokine signaling pathway WP3929,0.9969975378857058,0.1681713923185789,0.0005056877687883683,['HRAS'],0.9993220073218276,0,0,1
275,Vitamin D Receptor Pathway WP2877,0.9986593062411407,0.14736105957240317,0.00019769860914612574,['S100A6'],0.9993220073218276,0,0,1
276,Ciliopathies WP4803,0.9993220073218276,0.13336436634469917,9.045072984308419e-05,['CCDC28B'],0.9993220073218276,0,0,1
